Castor

Inside the Curavit and Lindus CRO deal

Curavit acquired Lindus Health’s CRO assets, bringing US and European trial delivery under one roof. Watch Joel Morse, Joel White, and Derk Arts talk through what it signals for sponsors.

On-demand

This webinar is on-demand. Get access to the webinar here.

Duration: 50 minutes

Watch Now Watch Now

What you will take from the recording

A candid conversation among people who know the business well, on a closely watched move in CRO consolidation and what it means for anyone running trials across the US and Europe.

Why one team across the US and Europe removes the seams that slow cross-Atlantic trials
Build versus buy, and why interoperability beats owning the whole stack
How controlling recruitment timelines gives sponsors budget and timing certainty
Where AI realistically fits in clinical research delivery today